Free Trial

Cannabix Technologies Inc. (OTCMKTS:BLOZF) Short Interest Update

Cannabix Technologies logo with Business Services background

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 7,200 shares, a decline of 81.8% from the May 15th total of 39,500 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 115,000 shares, the short-interest ratio is currently 0.1 days.

Cannabix Technologies Stock Performance

Shares of Cannabix Technologies stock traded down $0.00 during trading on Thursday, reaching $0.46. The company's stock had a trading volume of 53,613 shares, compared to its average volume of 93,440. The business's fifty day moving average price is $0.44 and its 200-day moving average price is $0.35. The firm has a market cap of $53.63 million, a price-to-earnings ratio of -23.24 and a beta of 1.85. Cannabix Technologies has a one year low of $0.20 and a one year high of $0.50.

About Cannabix Technologies

(Get Free Report)

Cannabix Technologies Inc, a technology company, develops marijuana breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use; MS breath sampler; and contactless alcohol breathalyzer, as well as breath collection units.

See Also

Should You Invest $1,000 in Cannabix Technologies Right Now?

Before you consider Cannabix Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannabix Technologies wasn't on the list.

While Cannabix Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines